#Estimated Cost of Kidney Cancer Surgery in India

[indiacancersurgerysite]

Saving Lives, Saving Costs: Affordable Kidney Tumor Surgery in India

👨‍⚕💉💊🩺Kidney cancer surgery in India is anticipated to be at least 60 to 70% more affordable compared to Western countries like the US and the United Kingdom. 👨‍⚕💉💊🩺

📌To make an appointment, you can contact us:-

✅Contact:- +91 9371770341 ✅Website:- www.indiacancersurgerysite.com ✅Email ID:-info@indiacancersurgerysite.com

[yourhealthrescue]

Apollo Gleneagles Hospitals, Kolkata: Cost, Reviews, and Procedures

Apollo Gleneagles Hospitals, Kolkata, is a trusted name in the healthcare sector, combining advanced medical expertise with a patient-first approach. Located in the heart of Kolkata, this hospital is a collaboration between Apollo Hospitals Group and Singapore’s Parkway Health, bringing together global standards of healthcare and cutting-edge medical technology.

With its focus on innovation, the hospital has gained a strong reputation among local and international patients alike. Specializing in a wide range of treatments, from heart care to organ transplants, Apollo Gleneagles is often the top choice for those seeking treatment in Apollo Hospital India.

Why Apollo Gleneagles Is a Top Choice for Patients

Choosing the right hospital is one of the most critical decisions you’ll make for your health. So, why do so many patients opt for Apollo Gleneagles?

1. Modern Technology and Advanced Infrastructure

Apollo Gleneagles is equipped with state-of-the-art medical tools and infrastructure. Whether it’s robotic surgeries, high-tech diagnostic imaging, or specialized ICUs, the hospital ensures world-class care.

2. Expert Medical Team

The hospital’s team consists of some of the best doctors and surgeons in the country. These professionals are not only highly trained but also deeply committed to providing compassionate care.

3. Wide Range of Specialties

Apollo Gleneagles is a one-stop destination for various medical treatments, including:

Heart Care: Angioplasties, bypass surgeries, and valve replacements.

Cancer Care: Advanced treatments like immunotherapy, radiotherapy, and targeted therapies.

Bone and Joint Care: Knee replacements and spinal surgeries with fast recovery times.

Organ Transplants: Highly successful liver and kidney transplants.

Brain and Nervous System Treatments: Specialized care for stroke, epilepsy, and Parkinson’s disease.

Understanding the Cost of Treatment at Apollo Gleneagles

For many, cost is a significant factor when choosing healthcare. The good news? Apollo Gleneagles delivers top-notch treatment at prices much lower than hospitals in Western countries, making it a preferred choice for international patients.

Estimated Costs of Popular Procedures

Here’s a general idea of what you can expect to pay for some common treatments:

Heart Bypass Surgery: Starts at $6,000.

Knee Replacement: Approximately $4,500.

Cancer Treatment: Starting at $5,000, depending on the type and stage.

Liver Transplant: Around $30,000.

Kidney Transplant: Roughly $18,000.

Please note that these are estimated costs, and the exact pricing will depend on the individual case.

Real Patient Stories: What People Say About Apollo Gleneagles

The best way to judge a hospital is through the experiences of its patients. Here are a few examples of what people say about Apollo Gleneagles:

“I had a heart bypass surgery here, and I couldn’t be happier with the care I received. The staff was friendly, and the doctors were incredibly skilled.” – Mark T., USA.

“Traveling to India for cancer treatment was a big decision, but Apollo Gleneagles exceeded all my expectations. Their advanced treatments gave me a new lease on life.” – Fatima A., UAE.

“Thanks to Medaviate, I found Apollo Gleneagles for my spinal surgery. Everything was seamless, from admission to follow-up.” – Joseph M., Nigeria.

How Medaviate Makes Your Medical Journey Hassle-Free

Planning medical travel can be overwhelming, but that’s where Medaviate steps in. As one of India’s most reliable healthcare facilitators, Medaviate connects patients from all over the world with top hospitals like Apollo Gleneagles.

Why Choose Medaviate?

Expert Guidance: We help you choose the best hospital and surgeon for your needs.

Personalized Service: We create customized plans to suit your budget and medical requirements.

Round-the-Clock Support: From visas to travel, our team ensures a hassle-free experience.

Let us help you find the care you deserve. Contact Medaviate at +91-97110 81535 for a trouble-free experience.

Specialized Services at Apollo Gleneagles

Here’s a closer look at the key specialties at Apollo Gleneagles:

1. Heart Care

From diagnosing heart issues to performing complex surgeries, the hospital offers a full spectrum of cardiac care.

2. Cancer Treatment

The hospital’s oncology department uses the latest techniques, like precision medicine and robotic surgery, to treat all types of cancer.

3. Orthopedics

Whether it’s a knee replacement or treatment for a sports injury, the orthopedic team ensures a quick and effective recovery.

4. Neurology

Apollo Gleneagles specializes in brain and spine treatments, offering innovative solutions for neurological disorders.

5. Organ Transplants

Known for its successful transplant surgeries, the hospital has a dedicated team for liver, kidney, and bone marrow transplant in India.

Planning Your Visit to Kolkata

If you’re traveling to Kolkata for medical treatment, you’ll find the city welcoming and well-connected. The city is well-connected via Netaji Subhas Chandra Bose International Airport, and Apollo Gleneagles offers dedicated international patient services.

For international patients, accommodations are available near the hospital, ensuring comfort during your stay.

FAQs

1. What makes Apollo Gleneagles Hospitals a preferred choice?

Apollo Gleneagles combines advanced medical technology, experienced specialists, and cost-effective treatments, making it a top choice for patients worldwide.

2. How can Medaviate assist with treatment in Apollo Hospital India?

Medaviate simplifies the process of accessing healthcare in India by connecting you with leading hospitals and providing comprehensive support throughout your journey.

3. What are the key specialties at Apollo Gleneagles Hospitals?

The hospital excels in cardiology, oncology, orthopedics, neurology, and transplantation services.

4. Are there accommodations near the hospital for international patients?

Yes, Apollo Gleneagles offers on-campus guest houses and assists in arranging nearby accommodations for patients and their families.

Conclusion

Choosing Apollo Gleneagles Hospitals, Kolkata, for your medical treatment is a step toward quality, reliability, and innovation in healthcare. When paired with Medaviate expert guidance, your medical journey becomes seamless and stress-free. With its focus on innovation, the hospital has gained a strong reputation among local and international patients alike. Specializing in a wide range of treatments, from heart care to organ transplants, Apollo Gleneagles is often the top choice for those seeking treatment in Apollo Hospital India.

[cmcshealth]

Affordable Brain Surgery for Foreign Patients

The brain is one of the five vital organs in humans. Brain Surgery is a critical and risky Surgery. For a successful Brain Surgery, the Neurosurgeons must be thoroughly trained about all aspects of the Brain Surgery. The Hospital infrastructure and the technology available to the surgeon also play a vital role in the surgery outcomes. CMCS Health, the leading Medical Tourism Provider Agency in India provides affordable and Safe Brain Surgeries for Foreigners. CMCS Health is associated with the Top Brain Surgeons and the Best Neurosurgery centers in India. Our Partner Neurosurgeons are extensively trained in the Top Neurology centers in the world and have vast experience in performing successful Brain Surgeries. The Top Neurosurgery Hospitals in India are well-equipped with the latest technologies for successful Brain Surgeries.

Who needs Brain Surgery?

Brain Surgery is recommended for patients who have the following medical conditions affecting the normal functioning of the Brain.

A brain Cyst or Brain Tumor (both malignant or cancerous and benign or non-cancerous) that has grown in size and is pressing against the nerves and blood vessels inside the brain.

Brain Hemorrhage or rupture of a blood vessel inside the brain.

Patients with Brain Arteriovenous Malformation (AVM) may also need brain Surgery.

Patients with Brain Blood Vessel Aneurysms may require Brain Surgery.

Patients with a blood clot in a brain blood vessel (Cerebral Thrombosis or Embolism).

Epilepsy, Parkinson’s disease, and essential tremors or movement disorder patients may benefit from Deep Brain Stimulation Surgery.

Patients especially children with fluid accumulation in the Brain (Hydrocephalus) may require Brain Surgery.

Cerebral cavernous Malformation patients may require Brain Surgery.

Dural Trear

Brain Abscess patients may also require Brain Surgery.

Types of Brain Surgery

Brain Surgery is performed by Neurosurgeons who are specially trained in the aspects of Brain Surgery. Brain Surgery could be Open Brain Surgery (craniotomy), minimally invasive brain surgery (MIS), and Non-Surgical Radiosurgery for the treatment of Brain medical conditions.

Craniotomy and craniectomy (open brain surgery)

Open Brain Surgeries Involve removing a bone part from the skull and accessing the brain. Craniotomy and Craniectomy are the most common forms of open Brain Surgery.

Minimally Invasive (MIS) Brain Surgery

Minimally invasive Brain Surgery or Keyhole Brain Surgery is also called Neuroendoscopic Brain Surgery. In endoscopic Brain Surgery, the Neurosurgeon accesses the Brain with small incisions as compared to Conventional Brain Surgeries. Minimally Invasive Brain Surgeries involve accessing the brain through small incisions or natural body openings, such as the nostrils or mouth.

Non-Invasive Brain Surgery

Non-Invasive Brain Surgery is Radiotherapy called Radiosurgery where pinpointed Radiation is given to affect Brain Tissues. Cynerknife and Gamma-Knife are stereotactic Radiosurgery for treating Brain medical conditions.

CMCS Health is a top medical tourism company in India. We offer medical tourism services such as finding the right doctor, the right hospital, and cost estimation for medical treatment in India for foreign patients. Some of the main countries are Bangladesh, South Africa, Egypt, Kenya, Saudi Arabia, Ethiopia, Nigeria, Uganda, Zambia, Sudan, Dubai, Namibia, Iraq, and so on. We provide free medical assistance aplastic anemia treatment cost, stomach cancer treatment, sickle cell treatment cost, the best hospital for heart valve replacement, heart valve surgery, arthroscopic surgery, bone marrow transplant cost, best liver transplant hospital, brain tumor surgery cost, cosmetic andplastic surgery, heart surgery, kidney transplant cost, spine tumor surgery,cancer treatment cost, lung transplant,liver transplant cost, top knee replacement surgeons, knee replacement surgery cost, top shoulder replacement surgeons, hip replacement surgery cost, best bone marrow hospital, etc.  If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Cmcshealth.com.

Source: https://cmcshealth1.blogspot.com/2024/12/affordable-brain-surgery-for-foreign.html

[trendingreportz]

Medical Robotics Market - Forecast(2024 - 2030)

Medical Robotics Market Overview

Medical Robotics Market was estimated at $7.34Bn in 2019, growing at a CAGR of 7.33% during the forecast period 2020–2025. It is a technology used in healthcare industry to aid healthcare professionals diagnose and treat diseases that corrects, restores or modifies bodily functions. It allows surgeons to carry out operations more precisely and in a less invasive way. It increases the accurateness of the operation with wide range of advantages such as decreased risk of infection, decreased post-operative pain and possess less life risks. It is used to perform repetitive tasks at high speeds, reliably with the help of telemanipulators without fatigue. Rehabilitation robots, Biorobots, Telepresence robots and others are the types of robots used to perform surgeries such as kidney transplant, gallbladder removal, hysterectomy and others. Non-invasive Radiosurgery Robots is used for the treatment of oncology by medical robotic system.

Key Takeaways

Rising technological advancements to cure patients through non-invasive methods are set to promote the scope of medical robotics market size.

Rising government initiatives with an objective of improving awareness about diagnosis and treatment; increasing instances of intricate medical conditions such as cancer, cardiovascular disease, gynecological diseases and others; increasing need of automation and advanced devices is estimated to contribute to the growth of the market.

Asia-Pacific region is estimated to record the fastest growth rate during the forecast period 2020–2025.

Request Sample

By Type —��Segment Analysis

In 2019, Surgical Robots segment dominated the Medical Robotics Market in terms of revenue is estimated to grow with a CAGR of 6.44%. It is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consist of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely. It is used in laparoscopic surgery with less blood loss, lesser pain and faster recovery. With better visualization it is able to operate more accurately to cure patients which are the key factor of the market’s growth.

Inquiry Before Buying

Geography — Segment Analysis

In 2019, the North America region dominated Medical Robotics Market in terms of revenue with a market share of 47%. It is owing to the relatively large federal grants from the government of health sector, government funding. The American Cancer Society introduced a nationwide program to increase the awareness about the benefits of medical robotics that is leading the market growth. Asia-Pacific region is estimated to record the fastest growth rate during the forecast period 2020–2025, owing to the presence of a large target population in China and India.

Drivers — Medical Robotics Market

Preference Of Non-Invasive Procedure

Medical robotic system uses non-invasive surgeries in the field of gynecology, cosmetology, open surgery, laparoscopic procedures, and others. These procedures offers negligible complications, diminish the threat of infections, reduce pain, and have quicker recovery. Traumatic injuries, cancers and cardiovascular disease raise the impact of surgical intervention in medical robotic market.

Schedule a Call

Challenges — Medical Robotics Market

High-Cost

It is quite evident that there is very less amount of hospitals that are capable of investing in the advanced instruments for the treatment of patients. Most of the hospital or clinical chains step back from having medical robotics owing to its high price. In the other hand, hospitals with these medical robots are forced to provide services at higher prices owing to the functional cost of the technology.

Medical Robotics Industry Outlook

Product Launches was the key strategy of the players in the Medical Robotics Industry. Medical Robotics top 10 companies include Intuitive Surgical Inc., Accuray Inc., Stryker Corporation, Hacoma AG. Major Robotics Ltd, Titan Medical Inc., Hansen Medical Inc., MedtEch S.A., Kuka Roboter GMBH, and Irobot Corporation.

Buy Now

Acquisitions/Product Launches

In February 2020, Intuitive Surgical Inc. acquired Orpheus Medical. This acquisition helped the company in enhancing its product portfolio, in offering information technology connectivity and archiving surgical video to hospitals around the world..

In July 2016, Stryker Corporation launched EMP tool that claims data and identify cost improvement and efficiency areas in order to improve outcomes and profitability in the orthopedics business.

[mymedtrips]

Find Shoulder Replacement Surgery Hospitals in India

Shoulder joint replacement surgery was first discovered in the United States in the 1950s to treat shoulder fractures. The shoulder is made up of three bones upper arm bone, shoulder blade, and collarbone. The shoulder is a ball-and-socket joint. The head of the upper arm bone fits into a shallow socket in the shoulder blade. This socket is known as a glenoid. The surfaces of the bones are covered with articular cartilage, a smooth substance that protects the bone and allows them to move easily. A thin, smooth tissue called assynovial membrane that covers all remaining surfaces inside the shoulder joint. This membrane makes less amount of fluid that lubricates the cartilage and removes almost any friction in the shoulder. The muscles and tendons that surround the shoulder give stability and support.

Shoulder replacement removes damaged parts of bone and replaces them with parts made of metal and plastic. This surgery is called shoulder arthroplasty.

Some conditions that can damage the joint include:

Osteoarthritis- it damages the cartilage that covers the ends of bones and helps joints move smoothly.

Rotator Cuff Injuries- it is a group of muscles and tendons that surrounds the shoulder joint. It damages the cartilage and bones in the shoulder joint.

Fractures- fractures of the upper end of the humerus may need replacement.

Osteonecrosis- A few types of shoulder conditions can affect blood flow to the humerus. When blood supply is disrupted to a part of bone, then it may collapse.

Shoulder Replacement Procedure:

Depending on the type of joint damage,

Anatomic total shoulder replacement- both the ball and socket are permanently replaced.

Reverse total shoulder replacement- Both the ball and the socket are removed and replaced, but the implants are reversed. The ball is joined to the shoulder blade and the socket is joined to the upper arm bone.

Partial shoulder damage- only the head of the joint is replaced when only the ball side of the joint is damaged.

Shoulder Replacement Surgery Cost in India 

The total cost of shoulder replacement surgery in India ranges start from around INR 1,50,000. As per the treatment, the shoulder replacement price in India is between Rs 1,50,000 to 2,00,000. This is the estimated shoulder replacement surgery cost in India can vary depending on various factors, including:

Hospital accommodation

Surgeon’s cost

Post-surgery consultation charges

Medicine

Type of implant used

Best Shoulder Replacement Surgery Hospitals in India

One advantage of choosing India for medical purposes is quite effective as it is affordable compared to other countries. So, one can easily find the best shoulder replacement surgery hospitals in India.

Here are some best hospitals for shoulder replacement surgery in India:

Artemis Hospital, Gurgaon

Medanta The Medicity, Gurgaon

Indraprastha Apollo Hospital, New Delhi

Best Shoulder Replacement Surgery Surgeons in India

India is known for its best medical facilities, anyone can find the best doctors for shoulder replacement surgery in India. Among all doctors, some best shoulder replacement doctors in India are

Dr Abhijit Dey

Dr Himanshu Gupta

Dr Vineesh Mathur

MyMedTrip is a leading medical tourism company in India. We are offering complete medical and healthcare services with medical consulting in India for foreign patients. We help patients in finding the best hospitals, top doctors, and good accommodations at affordable costs in India. We offer surgeries, treatment and transplant. Some of them are kidney transplant cost, heart transplant, bone marrow transplant cost, cancer treatment, liver transplant cost,  prostate cancer, best cardiologist in India, ovarian cancer, hip replacement surgery cost, knee replacement, brain tumor,  breast cancer surgery, orthopedic surgery cost in India, shoulder surgeons,best hospital for prostate treatment, orthopedic surgeons, liver cancer treatment, heart valve replacement, top heart hospital, knee surgeons, best Kidney transplant hospital in India and so on.

Source: https://mymedtrips.blogspot.com/2023/10/shoulder-replacement-surgery-hospitals.html

[filaantrocrowdfunding]

Government Schemes for Cancer Treatment

According to data from the cancer registry, 8,00,000 new instances of cancer are anticipated in India each year. Only 20% of Indians nationwide have health insurance. Over 80% of Indians are still without health insurance, some of whom may not be aware that they are eligible for government-sponsored insurance.

Apart from cancer, there are other chronic diseases like arthritis, stroke, asthma, heart disease and others that can break a patient’s hopes to get cured. Living with chronic diseases can be depressing in itself especially when a patient has to stay isolated. But the problems with chronic diseases just do not end here. Following specific routines and diets, and undergoing prolonged, rigorous treatments that are pretty expensive that add to the burden of chronic diseases.

Many a time, a person’s entire life savings might get used to afford the prolonged treatment of chronic illnesses. Health insurance claims too, are not enough to meet the ends in such situations.

1. The Health Minister’s Cancer Patient Fund (HMCPF) is a programme offered by the Ministry of Health & Family Welfare under Rashtriya Arogya Nidhi. Patients who are below the poverty level can access this. Follow these steps if you want to avail of the benefits of this scheme:

1. Fill out the form, have the treating physician sign it, and get the medical director of the government hospital, institution, or regional cancer centre to countersign it.

2. A copy of the income certificate should be submitted.

3. Copy of the ration card must be submitted.

2. Central Government Health Scheme

The scheme is for both active and retired Central Government personnel as well as their dependents, CGHS is applicable. Other than the hospitals established under the CGHS, cancer treatment is available at approved prices from any hospital.

To avail the benefits:

Download the application, then submit it with your eligibility documentation. The members who are eligible for ar-

Every member of the Central Government receives compensation from Central Civil Estimates as well as their dependent family members who live in CGHS-covered regions.

Central Government Pensioners/families receiving pensions under central civil estimates, as well as their eligible dependent relatives.

Both current and former members of congress

Former vice presidents

Supreme Court Justices Currently Serving and Retired.

Retired High Court judge.

Employees and retirees of a few autonomous or statutory organisations have access to Delhi’s CGHS facilities.

Personnel from the Delhi Police only in Delhi.

Railroad Board personnel

Employees of the Post and Telegraph Department.

3. The Prime Minister’s National Relief Fund

In response to a request made by the country’s then-prime minister, Pt. Jawaharlal Nehru, the Prime Minister’s National Relief Fund (PMNRF) was created with financial support from the general people to aid those who had been forcibly evacuated.

Originally meant for victims of natural catastrophes, it offers partial coverage for procedures including heart surgery, kidney transplants, and cancer treatment. Follow this procedure to avail the benefits.

1. See whether the hospital that you are taking treatment is included on this list.

Download the application.

-Send two passport-sized photos of the patient, a copy of residency documentation, an original medical certificate outlining the condition and expected cost, and an income certificate to the PMO.

4. State Illness Assistance Fund

Illness Assistance Funds have been established by States and Union territories, with the help of the legislature, and provide coverage for cancer treatment at government hospitals within the state up to Rs. 1 lakh. Despite the fact that this programme is not available in all nations, except for Assam, Nagaland, Odisha, Dadra and Nagar Haveli, Lakshadweep, Andaman and Nicobar Islands, Jammu & Kashmir, Ladhak, and Daman and Diu.

To avail:

Find out whether your state provides SIAF.

Fill out the application form

and submit it to the government hospital with a BPL card and two photos.

5. National Health Protection Scheme

The National Health Protection Scheme, an Ayushman Bharat project, covers secondary and tertiary care hospitalisation up to 5 lakh rupees per family per year. It provides low-cost medical care to more than 50 crore Indian citizens.

Two sections make up the main goal of the Ayushman Bharat NHPS. Visit this website to find out more information.

These schemes can help cancer patients and their families shake off a part of the burden of expensive treatments for chronic diseases. Another way to cope with such expensive treatments is through medical crowdfunding.

Medical crowdfunding can assure solving financial constraints when chronic diseases demand prolonged and expensive treatments. With crowdfunding, there is no restriction on how many times you can raise funds. For prolonged treatment that needs many sessions of medical support, you can fundraise as many times as funds are needed. Filaantro is one such trustworthy online crowdfunding platform that raises funds for medical emergencies and for chronic diseases. It has a user-friendly interface. The process of running the online fundraiser takes place with a few simple steps of registration and filling in details.

Visit: https://filaantro.org/ to know more

[tiapandayblogs]

Government Schemes for Cancer Treatment.

According to data from the cancer registry, 8,00,000 new instances of cancer are anticipated in India each year. Only 20% of Indians nationwide have health insurance. Over 80% of Indians are still without health insurance, some of whom may not be aware that they are eligible for government-sponsored insurance. 

Apart from cancer, there are other chronic diseases like arthritis, stroke, asthma, heart disease and others that can break a patient's hopes to get cured. Living with chronic diseases can be depressing in itself especially when a patient has to stay isolated. But the problems with chronic diseases just do not end here. Following specific routines and diets, and undergoing prolonged, rigorous treatments that are pretty expensive that add to the burden of chronic diseases. 

Many a time, a person's entire life savings might get used to afford the prolonged treatment of chronic illnesses. Health insurance claims too, are not enough to meet the ends in such situations. 

1. The Health Minister's Cancer Patient Fund (HMCPF) is a programme offered by the Ministry of Health & Family Welfare under Rashtriya Arogya Nidhi. Patients who are below the poverty level can access this. Follow these steps if you want to avail of the benefits of this scheme: 

1. Fill out the form, have the treating physician sign it, and get the medical director of the government hospital, institution, or regional cancer centre to countersign it.

2. A copy of the income certificate should be submitted.

3. Copy of the ration card must be submitted.

2. Central Government Health Scheme

The scheme is for both active and retired Central Government personnel as well as their dependents, CGHS is applicable. Other than the hospitals established under the CGHS, cancer treatment is available at approved prices from any hospital. 

To avail the benefits: 

Download the application, then submit it with your eligibility documentation. The members who are eligible for ar-

Every member of the Central Government receives compensation from Central Civil Estimates as well as their dependent family members who live in CGHS-covered regions.

Central Government Pensioners/families receiving pensions under central civil estimates, as well as their eligible dependent relatives.

Both current and former members of congress

Former vice presidents

Supreme Court Justices Currently Serving and Retired.

Retired High Court judge.

Employees and retirees of a few autonomous or statutory organisations have access to Delhi's CGHS facilities.

Personnel from the Delhi Police only in Delhi.

Railroad Board personnel

Employees of the Post and Telegraph Department.

3. The Prime Minister’s National Relief Fund

In response to a request made by the country's then-prime minister, Pt. Jawaharlal Nehru, the Prime Minister's National Relief Fund (PMNRF) was created with financial support from the general people to aid those who had been forcibly evacuated.

Originally meant for victims of natural catastrophes, it offers partial coverage for procedures including heart surgery, kidney transplants, and cancer treatment. Follow this procedure to avail the benefits.

1. See whether the hospital that you are taking treatment is included on this list.

Download the application.

-Send two passport-sized photos of the patient, a copy of residency documentation, an original medical certificate outlining the condition and expected cost, and an income certificate to the PMO.

4. State Illness Assistance Fund

Illness Assistance Funds have been established by States and Union territories, with the help of the legislature, and provide coverage for cancer treatment at government hospitals within the state up to Rs. 1 lakh. Despite the fact that this programme is not available in all nations, except for Assam, Nagaland, Odisha, Dadra and Nagar Haveli, Lakshadweep, Andaman and Nicobar Islands, Jammu & Kashmir, Ladhak, and Daman and Diu. 

To avail: 

Find out whether your state provides SIAF.

Fill out the application form

and submit it to the government hospital with a BPL card and two photos.

5. National Health Protection Scheme

The National Health Protection Scheme, an Ayushman Bharat project, covers secondary and tertiary care hospitalisation up to 5 lakh rupees per family per year. It provides low-cost medical care to more than 50 crore Indian citizens.

Two sections make up the main goal of the Ayushman Bharat NHPS. Visit this website to find out more information.

These schemes can help cancer patients and their families shake off a part of the burden of expensive treatments for chronic diseases. Another way to cope with such expensive treatments is through medical crowdfunding. 

Medical crowdfunding can assure solving financial constraints when chronic diseases demand prolonged and expensive treatments. With crowdfunding, there is no restriction on how many times you can raise funds. For prolonged treatment that needs many sessions of medical support, you can fundraise as many times as funds are needed. Filaantro is one such trustworthy online crowdfunding platform that raises funds for medical emergencies and for chronic diseases. It has a user-friendly interface. The process of running the online fundraiser takes place with a few simple steps of registration and filling in details.

Visit: https://filaantro.org/blog/government-schemes-for-cancer-treatment/ to know more

[healthcareandwellness-blog]

Laparoscopic Tumor Ablation Market: Introduction

Laparoscopic tumor ablation is a laparoscopic process of removing tumors in human organs such as liver, bone, kidney and lungs. This treatment is minimally invasive, and requires thermal energy to cool tissues as per the requirement during the surgeries. The ablation can be done by various treatment methods such as RF, chemical, microwave, etc.

 Market Dynamics

Increasing cancer cases across the world is the key factor significantly contributing to the growth of laparoscopic tumor ablation market. According to the estimates by World Health Organization (WHO), around 13% of the entire global population have the chance to suffer from cancer every year. Moreover, there is a rise of over 70.0% in cancer cases in the next few years.

Moreover, there are more than 100 cancer types which require laparoscopic tumor ablation treatments. This factor is majorly anticipated to boost the laparoscopic tumor ablation market over the projected period.

Extensive adoption of minimally invasive technologies for the tumor removal treatments will further boost the market globally over the coming years. Increasing geriatric population is another factor which is acting as one of the other significant factors which helps the market to grow in the coming years. The market might be restrained by the stringent regulations regarding the treatment, and also about the need for treatment approvals.

 Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/190

 By Technology Type

By technology type, the global laparoscopic tumor ablation market has been segmented into radiofrequency (RF) ablation, microwave ablation, cryotherapy, chemical ablation, and others which include HIFU, laser ablatio, etc. Among all types of technologies, the radiofrequency technology for laparoscopic tumor ablation is expected to hold a substantial market share over the projected period. This technology is highly prominent in removing solid tumors in human organs such as orthopedic. The dominant market share can be further attributed towards the rising usage in solid tumor excision technologies. Additionally, high efficiency and specificity of radiofrequency laparoscopic tumor ablation technology is further anticipated to grow over the projected period.

 By Application

By application, the laparoscopic tumor ablation market has been segmented into liver, lung, orthopedic, and others, which include kidney, ENT, etc. Laparoscopic tumor ablation market for liver application is predicted to account for the prime market share over the forecast period. This is majorly attributed by the increasing prevalence of liver cancer cases among males over females.

Laparoscopic tumor ablation market for lung application is anticipated to grow at the highest CAGR over the forecast period. Increasing lung cancer incidences is predicted to propel the market over the upcoming years. Lung cancer treatment prominently requires radiofrequency laparoscopic tumor ablation, for the destruction of tumor cells by the generation of heat. In 2018, 234,030 new cases of lung cancer are identified, out of which 154,050 deaths are registered, according to American Cancer Society.

 By Region

North America laparoscopic tumor ablation market is predicted to emerge as the dominating region with a prime market share over the forecast period. Increasing government support for the development of quality healthcare facilities, coupled with flexible healthcare reimbursement policies, and increasing cancer cases in this region will primarily drive the regional market. For instance, some U.S. state governments such as Massachusetts mandated the purchase of health insurance policies, and also provided subsidized health insurance schemes for people in the low-income levels.

The prime market share is majorly attributed by the U.S. region, as the Patient Protection and Affordable Care Act (PPACA), is significantly promoting quality and also making the health insurances affordable to all people, which helps to reduce the healthcare costs.

Asia Pacific laparoscopic tumor ablation market is expected to witness a rewarding growth over the projected period majorly due to the rising prevalence of several cancer types, along with increasing geriatric population in this region. Moreover, rising demand of minimally invasive surgeries, and favorable steps taken by various governing bodies of China, Japan, India, South Korea, and Australia for modernizing the healthcare infrastructure will significantly favor the regional market growth over the projected period.

 Competitive Landscape

Some of the prominent players in the global laparoscopic tumor ablation market include Angiodynamics, Inc., Boston Scientific Corporation, Galil Medical, Inc., EDAP TMS S.A., Healthtronics, Inc., Medtronic, Plc, Mermaid Medical, Inc., Mesonix, Inc., Neuwave Medical, Inc. and Sonacare Medical, LLC among several others.

 For more information about this report @ https://www.insightsandreports.com/industry-reports/laparoscopic-tumor-ablation-market

 Many key players in this market are focusing more on launching new product, and also working towards the enhancement of product efficiency. To meet the growing requirements and expectations, these players are adopting various strategies to improve their respective positions in the global laparoscopic tumor ablation market. For instance, in October 2015, Galil Medical Inc. launched a new variant of cryoablation needles, IceFORCE 2.1CX and IcePearl 2.1 CX, which further helped the company to expand its product portfolio.

[decisionforsight]

Global Erythropoietin Drugs Market

Global Erythropoietin Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Erythropoietin is a glycoprotein hormone released by the human renal system. This hormone helps in the production of red blood cells that carry oxygen from the lungs to the various parts of the body. Erythropoietin drugs control the process of erythropoiesis, i.e. the production of red blood cells. These drugs are mainly used in the treatment of chemotherapy-induced anaemia, cancer, and HIV. The growing population across the globe along with increasing HIV, cancer, and chronic renal diseases is the major factor driving the erythropoietin drugs market worldwide. The global erythropoietin drugs market is accounted approximate USD 8.9 billion in 2020 and it is expected to reach approximate USD 27.8 million by 2030 with a CAGR of 12.1% during forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020189

Market Dynamics and Factors:

The increasing number of patients suffering from anaemic conditions due to HIV, cancer, and end-stage renal diseases (ESRD), favourable reimbursements, and the rapid commercialisation of erythropoietin drugs are the major factors driving the growth of the erythropoietin drugs market. For instance, according to Centres for Disease Control and Prevention (CDC), around 5.5 million ambulatory care patients suffer from anaemia due to nutritional deficiency, while chronic disease is the second most dominant cause. The surge in drug patent expiration has increased the emphasis on the usage of biosimilar medicines having the same therapeutic effect with lower cost. This is another key factor that will fuel the growth of the erythropoietin drugs market in the coming future. Other major factors driving the global erythropoietin drugs market include inactive lifestyles attributing to deficiencies in iron, vitamin B12, and folic acid resulting in anaemic conditions; increase in blood transfusion during surgeries and treatments; and rising geriatric population. However, high costs of erythropoietin drugs and longer duration of treatments are some restraining factors that may hinder the growth of the market to some extent. 

Market Segmentation:

Global Erythropoietin Drugs Market – By Drug Class

Biologics

Biosimilar

Global Erythropoietin Drugs Market – By Product

Epoetin-Alfa

Epoetin-Beta

Darbepoetin-Alfa

Others

Global Erythropoietin Drugs Market – By Application 

Cancer

Haematology

Renal Diseases

Neurology

Global Erythropoietin Drugs Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020189

Geographic Analysis:

North America is expected to be the most dominant region for erythropoietin drugs in terms of revenue market share during the forecast period. Growing incidences of chronic kidney diseases (CDK), cancer, and HIV; presence of excellent healthcare facilities; and increasing investments in novel drug discoveries are some of the major factors responsible for the market dominance of the North American region. For instance, in the U.S, around 20 million people suffer from chronic kidney diseases out of which 2-4 million are having anaemia. The presence of major erythropoietin drug manufacturers in North America further enhances the growth of the market in the region. The existence of a significant amount of geriatric population in the European region has made it the second most dominant market for erythropoietin drugs. The Asia Pacific region is anticipated to be the fastest growing market for erythropoietin drugs during the forecast period. The rapid development in healthcare infrastructure, enhanced purchasing power, rising medical tourism are certain factors attributing towards the market growth in the APAC region. Rising prevalence of chronic diseases in the APAC region presents a lucrative opportunity for biosimilars with low cost of therapy in the region. 

Competitive Scenario:

The key players operating in the global erythropoietin drugs market are –

Johnson & Johnson, Roche Holding AG, Biocon Limited, Celltrion Inc., LG Life Sciences Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Amgen Inc., Teva Pharmaceutical Industries Ltd. 

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020189 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Erythropoietin Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Erythropoietin Drugs Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Erythropoietin Drugs Market most.

The data analysis present in the Global Erythropoietin Drugs Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Erythropoietin Drugs Market business.

The 2021 Annual Global Erythropoietin Drugs Market offers:

100+ charts exploring and analysing the Global Erythropoietin Drugs Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Erythropoietin Drugs Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020189 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[cmcshealth]

Liver Transplant in India

The Liver is one of the five Vital Organs in the human body. The Liver performs many important functions for the proper functioning of the Human Body. Any changes or abnormalities in liver tissues can affect the quality of life and may need medical treatments. Certain Medical Conditions like Cirrhosis of the Liver, primary Liver cancer, or an ill-functioning Liver may require a Liver Transplant to save the life of the patient.

What is a Liver Transplant Surgery?

A liver Transplant is a life-saving Surgery performed by a specially trained gastroenterology surgeon to replace the damaged or faulty liver in a patient with a healthy liver either from a deceased donor liver or the portion of the Liver obtained from a living liver donor. Liver Transplant Surgery is a complicated surgery and requires great expertise from gastroenterology surgeons and a proper hospital setup.

Why a Liver transplant is needed?

A liver transplant is needed when the liver tissues are damaged and the Liver is unable to perform its functions. An end-stage liver disease patient requires a Liver Transplant for survival. A liver Transplant is also indicated for the treatment of primary Liver Cancer when the cancer is localized and the tumor size is smaller. Following medical conditions may make a Gastroenterologist or Hepatologist recommend a Liver Transplant for a patient:

Liver Cirrhosis

Alcohol-induced liver damage due to chronic alcoholism

Non-alcoholic fatty liver disease

Hemochromatosis

Wilson's disease

Primary biliary Cholangitis (PBC)

Primary sclerosing cholangitis (PSC)

Biliary atresia (generally for pediatric liver patients)

Autoimmune hepatitis

Acute Liver failure

Primary Liver cancer

Types of Liver Transplants

Liver Transplants are done either with a deceased liver donor or a healthy liver donor.

Deceased Donor Liver Transplant

Orthotopic liver transplant is replacing the damaged liver in an end-stage liver disease patient with a healthy liver procured from a deceased donor.

Split liver transplants are also orthotopic liver transplants where the deceased donor's liver is split into two and transplanted into two end-stage liver disease patients. In Split liver transplant surgery, the left lateral cadaveric liver is transplanted into a child, and the right extended liver is transplanted into an adult patient.

Living Donor Liver Transplants

Living donor liver transplants are done by taking a portion of the liver from an HLA matching Liver Donor. The Donor reverts to the full functionality of the Liver within 6 weeks of liver donation and lives a perfectly normal life.

CMCS Health is a leading medical tourism company in India. We offer medical tourism services such as finding the right doctor, the right hospital, and cost estimation for medical treatment in India for foreign patients. Some of the main countries are Bangladesh, South Africa, Egypt, Kenya, Saudi Arabia, Ethiopia, Nigeria, Uganda, Zambia, Sudan, Dubai, Namibia, Iraq, and so on. We provide free medical assistance aplastic anemia treatment cost, stomach cancer treatment, sickle cell treatment cost, the best hospital for heart valve replacement, heart valve surgery, arthroscopic surgery, bone marrow transplant cost, best liver transplant hospital, brain tumor surgery cost, cosmetic andplastic surgery, heart surgery, kidney transplant cost, spine tumor surgery,cancer treatment cost, lung transplant,liver transplant cost, top knee replacement surgeons, knee replacement surgery cost, top shoulder replacement surgeons, hip replacement surgery cost, best bone marrow hospital, etc.  If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Cmcshealth.com.

Source: https://cmcshealth1.blogspot.com/2024/11/liver-transplant-in-india.html

[market-research-future]

Operating Table Parts Market Insights, Future Outlook, Growth and Emerging Trends To 2027

Market Highlights

Increasing number of surgeries including bariatric surgeries, orthopedic surgeries, urology surgeries, and other, growing obese & geriatric population and favorable reimbursement policies drives the growth of global operating table parts market during the forecast period. However, factors such as high therapeutic surgery cost and related side effects, and the high cost of operating tables are projected to restrain the market growth.

The global operating table parts market is expected to grow at a CAGR of 3.80% during forecast period.

Segmentation

The global operating table parts market is segmented on the basis of product type, procedure, accessory, and end user.

On the basis of the product type, the market is segmented into general surgical tables, specialty surgery table. The specialty surgery table segment is sub-segmented into orthopedic surgery table, neurological operating table, urology and cysto tables, and others. On the basis of the procedure, the market is categorized into anesthesia, orthopedic, neurology, urology, ophthalmic/ENT, and others. On the basis of the accessory, the market is segmented into standard accessory and patient supports. The standard accessory segment is sub-segmented into clamps & sockets, restraint straps, anesthesia aids, accessory cart, general, and others. The patient supports segment is sub-segmented into body supports, leg supports, tabletop extensions, and others. On the basis of the end user, the market is segmented into hospitals, clinics, ambulatory surgical center, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/operating-table-parts-market-5802

Regional Analysis

The Americas leads the global operating table parts market. Favorable reimbursement policies and a well-developed healthcare sector drives the market growth within the region. Moreover, changing lifestyle and increasing healthcare expenditure boosts the market. Europe stands second in the global operating table parts market due to increasing number of surgeries and government support for research & development within the region. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe leads the market in the developed economies like Italy, U.K, France, and others. Asia Pacific is estimated to be the fastest growing region for the market. This can be attributed due to the increasing number of therapeutic surgeries, growing geriatric & obese population, and presence of developing economies like India, China, and Australia within the region. The Middle East & Africa has the least share in the global operating table parts market due to the presence of poor economies, lack of healthcare services and stringent government policies, especially within the Africa region.

Key Players

The key players for the global operating table parts market are Hill-Rom Holdings, Inc., AGA SANITÄTSARTIKEL GMBH, Alvo, Denyers International Pty, Merivaara, Mizuho OSI, Lojer Group, Siemens AG, STERIS plc., SKYTRON, Stryker, Getinge AB, Mindray, Berchtold GmbH & Co. KG, Eschmann Holdings Ltd, Akrus, Oricare, Medifa-hesse, OPT SurgiSystems, NUOVA BN, and others.

Browse Related Reports at:

Kidney Function Test Market | Type, Technology and Growth Forecast to 2027

Endometrial Cancer Market Application, Growth, Trends, Size | Global Industry Analysis 2027

Palliative Care Market Research Report –Global Forecast to 2027| MRFR

[indiamedicaltourism]

Kidney Cancer Treatment in India for Foreigners

Kidney cancer is known as renal cell cancer. Nowadays kidney cancer is most common in India. It starts inside the kidney, where blood is filtered. Kidney cancer is a harmful disease that attacks the healthy cells of the kidneys. It can be dangerous in the last stages. Our kidneys are two bean-shaped organs. Cancerous cells start to grow uncontrollably and form tumors in the kidneys. This tumor can extend beyond the kidney. Some cells can detach and spread to other parts of the body. In adults, renal cell carcinoma is a very common type of kidney cancer. Other less common types of kidney cancer can happen. Surgery is the most preferable treatment for different kidney diseases. A kidney cancer patient may have these symptoms, a lump can be felt in the abdomen, fatigue and unexplained weight loss, anemia, passing of blood in urine, unexplained fever for lasts weeks, etc. There are many types of kidney cancer.

Renal cell carcinoma - renal cell carcinoma has three main types clear cell, renal cell cancers, and papillary chromophobe 

Urothelial carcinoma - this type is used to be called transitional cell cancer (TCC) of the kidney or ureter. It can change shape and stretch. The renal pelvis is the place of the kidney where urine collects. 

Sarcoma - This is a rare type of soft tissue sarcoma of the kidney. This means the cancer started in the connective tissue muscles, nerves, fat, blood vessels, and fibrous tissue of the kidney. 

Wilms tumor - this is a type of kidney cancer that can affect children. It is different from kidney cancer in adults.

Lymphoma  

This type of kidney cancer can develop in both kidneys. In rare cases, kidney lymphoma can start as a tumor in the kidney.

The cancer spreads outside the kidney, to distant parts of the body, such as the liver, lungs, or bones.

Kidney Cancer Treatment Cost in India

Kidney cancer treatment costs in India are much lower than in other countries. The accurate cost is based on the diagnostic test, cost-affecting factors are doctor experience, selected hospital, accommodation, post-surgery care, etc. The average cost of kidney cancer treatment in India starts from 3600 USD and goes up to 7500 USD.

Best Kidney Cancer Treatment Doctors in India

Finding the best doctor for kidney cancer treatment can be crucial but India has several kidney cancer treatment surgeons. These doctors have years of experience in medical technology and work in reputable hospitals. They offer cutting-edge treatments and compassionate care, giving hope to numerous patients. Some best doctor's names are include:

Dr VineetGovinda Gupta (DM Medical Oncology–Gold Medalist, renal cancer specialist)

Dr.ArunHalankar (Nephrologist, MBBS, MD, Fellowship, USA)

Dr. Raghunath S.K (consultant and director of the uro-oncology and robotic surgery department)

Dr Pradeep Bansal (Kidney Transplant & Cancer Specialist)

Dr. Deepak Dubey (HOD & Chairman of Urology Department and Renal Transplantation)

Dr.SureshAdvani (Memberships of (ISO) Padma Shri and Padma Bhushan winner 

Top Kidney Cancer Treatment Hospitals in India

 India has many best hospitals for kidney cancer treatment. Now India is known globally for advanced medical technology of kidney cancer treatment. They provide radiofrequency ablation (RFA), cryoablation, radiation therapy, targeted drug therapy, immunotherapy, and chemotherapy as per the stage of cancer and the patient's overall health. Some of the best kidney cancer treatment hospitals' names are given below:

Tata Memorial Hospital (Mumbai)

Devasya Hospital (Ahmedabad )

All India Institute of Medical Sciences (AIIMS) (New Delhi)

Fortis Memorial Research Institute (FMRI) (Gurugram)

Rajiv Gandhi Cancer Institute & Research Centre (New Delhi)

Apollo Hospitals (Chennai)

Medanta- The Medicity (Gurgaon)

Al AfiyaMedi Tour is a leading medical tourism company in India. We offer medical tourism services such as finding the right doctor, the right hospital, and cost estimation etc. Some of the main countries are Bangladesh, South Africa, Egypt, Uganda, Zambia, Sudan, Dubai, Namibia, Iraq, Kenya, Saudi Arabia, Ethiopia, Nigeria, and so on. We provide free medical assistance for TURP surgery cost, lung cancer treatment, blood cancer treatment cost, the best hospital for heart valve replacement, arthroscopic surgery, bone marrow transplant cost, best liver transplant hospital, cosmetic andplastic surgery, heart surgeryliver transplant cost, top knee replacement surgeons, etc.

Source:https://alafiyameditour1.blogspot.com/2024/05/kidney-cancer-treatment-in-india-for.html

[mymedtrips]

Shoulder Replacement Surgery Hospitals in India

Shoulder joint replacement surgery was first discovered in the United States in the 1950s to treat shoulder fractures. The shoulder is made up of three bones upper arm bone, shoulder blade, and collarbone. The shoulder is a ball-and-socket joint. The head of the upper arm bone fits into a shallow socket in the shoulder blade. This socket is known as a glenoid. The surfaces of the bones are covered with articular cartilage, a smooth substance that protects the bone and allows them to move easily. A thin, smooth tissue called assynovial membrane that covers all remaining surfaces inside the shoulder joint. This membrane makes less amount of fluid that lubricates the cartilage and removes almost any friction in the shoulder. The muscles and tendons that surround the shoulder give stability and support.

Shoulder replacement removes damaged parts of bone and replaces them with parts made of metal and plastic. This surgery is called shoulder arthroplasty.

Some conditions that can damage the joint include:

Osteoarthritis- it damages the cartilage that covers the ends of bones and helps joints move smoothly.

Rotator Cuff Injuries- it is a group of muscles and tendons that surrounds the shoulder joint. It damages the cartilage and bones in the shoulder joint.

Fractures- fractures of the upper end of the humerus may need replacement.

Osteonecrosis- A few types of shoulder conditions can affect blood flow to the humerus. When blood supply is disrupted to a part of bone, then it may collapse.

Shoulder Replacement Procedure:

Depending on the type of joint damage,

Anatomic total shoulder replacement- both the ball and socket are permanently replaced.

Reverse total shoulder replacement- Both the ball and the socket are removed and replaced, but the implants are reversed. The ball is joined to the shoulder blade and the socket is joined to the upper arm bone.

Partial shoulder damage- only the head of the joint is replaced when only the ball side of the joint is damaged.

Shoulder Replacement Surgery Cost in India 

The total cost of shoulder replacement surgery in India ranges start from around INR 1,50,000. As per the treatment, the shoulder replacement price in India is between Rs 1,50,000 to 2,00,000. This is the estimated shoulder replacement surgery cost in India; shoulder replacement surgery cost in India can vary depending on various factors, including:

Hospital accommodation

Surgeon’s cost

Post-surgery consultation charges

Medicine

Type of implant used

Best Shoulder Replacement Surgery Hospitals in India

One advantage of choosing India for medical purposes is quite effective as it is affordable compared to other countries. So, one can easily find the best shoulder replacement surgery hospitals in India.

Here are some best hospitals for shoulder replacement surgery in India:

Artemis Hospital, Gurgaon

Medanta The Medicity, Gurgaon

Indraprastha Apollo Hospital, New Delhi

Best Shoulder Replacement Surgery Surgeons in India

India is known for its best medical facilities, anyone can find the best doctors for shoulder replacement surgery in India. Among all doctors, some best shoulder replacement doctors in India are

Dr Abhijit Dey

Dr Himanshu Gupta

Dr Vineesh Mathur

MyMedTrip is a leading medical tourism company in India. We are offering complete medical and healthcare services with medical consulting in India for foreign patients. We help patients in finding the best hospitals, top doctors, and good accommodations at affordable costs in India. We offer surgeries, treatment and transplant. Some of them are kidney transplant cost in India, heart transplant, bone marrow transplant cost in India, cancer treatment, liver transplant in India,  prostate cancer, best cardiologist in India, ovarian cancer, hip replacement surgery cost in India, knee replacement, brain tumor,  breast cancer surgery in India, orthopedic surgery cost in India, shoulder surgeons,best hospital for prostate treatment in India, orthopedic surgeons, liver cancer treatment in India, heart valve replacement, top heart hospital in India, knee surgeons, best Kidney transplant hospital in India and so on. Source: https://mymedtrips.blogspot.com/2023/10/shoulder-replacement-surgery-hospitals.html

[ka43270]

Neuroblastoma Drug Market Industry Applications, Products and Business Opportunity

Market Analysis and Insights: Neuroblastoma Drug Market

Neuroblastoma Drug Market Mechanism of Action Type (Alkylating agents, Antimetabolites, Antibiotics, Microtubule Inhibitors, Monoclonal Antibodies), Drug Type (Cyclophosphamide, Cisplatin, Vincristine, Doxorubicin, Etoposide, Topotecan, Busulfan and Melphalan), Diagnosis Type (Physical Test, Urine and Blood Test, Imaging Test, Tissue Sample Testing, Bone Marrow Sample Testing), Treatment Type (Surgery, Chemotherapy, Radiotherapy, Immunotherapy, Bone Marrow transplantation, Retinoid Therapy, Targeted Delivery of Radionuclides), Route of Administration (Oral, Intravenous and others), ), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends & Forecast to 2026

Request Sample is Available @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neuroblastoma-drug-market

Market Analysis: Global Neuroblastoma Drug Market 

Global neuroblastoma drug market is rising gradually to an estimated steady CAGR of 4.2% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the growing awareness towards diagnosis and treatment of neuroblastoma cancer, increase in the prevalence of childhood cancers, the rising birth rate, growing medical spending, increasing global healthcare expenditure and technological advancements in pharmaceuticals research.

Market Definition: Global Neuroblastoma Drug Market 

Neuroblastoma is a childhood cancer most commonly occurs in children below the age of 5 years, most often found in the small glands on top of the kidneys (adrenal glands).Neuroblastoma can develop in abdominal parts of the body where the group of nerve cells are present including chest, neck and near the spinal region. The neuroblastoma may cause due to the immature cell growth or mutation in the gene responsible for controlling cell proliferation. Neuroblastoma patient experiences symptoms such as fatigue, loss of appetite and fever. There may be a lump or compression of tissues in the affected area.

As per the April 2018 report of American Society of clinical oncology (ASCO), in the U.S. around 700 children get diagnosed with neuroblastoma every year and it indicates that amongst children younger than 1 year, neuroblastoma is the most common cancer and most frequently found in boys to that of girls.

Market Drivers

Growing awareness towards diagnosis and     treatment of neuroblastoma cancer drives the market growth

High prevalence of childhood cancers     acts as a catalyst for the growth of the market

Increasing birth rate across the world     enhances the market growth

Rising research on neuroblastoma     treatment and increasing spending on cancer treatment elevates the market     growth

Market Restraints

Lack of awareness among the people about     neurocarcinoma treatment hinders the market growth

Patent expiry from many companies and     introduction of generic drugs is expected to restrain the growth of the     market

High cost of treatment and an adverse     side effect of treatment are the major restraint of the market

Shortage of trained healthcare     specialists is hampering the market

For Further Detailed insights and ‘Any Query About this report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-neuroblastoma-drug-market

Segmentation: Global Neuroblastoma Drug Market 

Mechanism of Action Type

Alkylating agents

Antimetabolites

Antibiotics

Microtubule Inhibitors

Monoclonal Antibodies

By Drug Type

Cyclophosphamide

Cisplatin

Vincristine

Doxorubicin

Etoposide

Topotecan

Busulfan

Melphalan

By Diagnosis Type

Physical Test

Urine and Blood Testing

Imaging Test

Tissue Sample Testing

Bone Marrow Sample Testing

By Treatment Type

Surgery

Chemotherapy

Radiotherapy

Immunotherapy

Bone Marrow transplantation

Retinoid Therapy

Targeted Delivery of Radionuclides

By End users

Hospitals

Homecare

Specialty Clinics

Surgical centers

Others

By Geography

 U.S.

 Canada

 Mexico

 Brazil

 Argentina

 Rest of South America

 Germany

 France

 United Kingdom

 Italy

 Spain

 Russia

 Turkey

 Belgium

 Netherlands

 Switzerland

 Rest of Europe

 Japan

 China

 South Korea

 India

 Australia

 Singapore

 Thailand

 Malaysia

 Indonesia

 Philippines

 Rest of Asia Pacific

 South Africa

 Egypt

 Saudi Arabia

 United Arab Emirates

 Israel

 Rest of Middle East & Africa

Request for complete Toc @ https://www.databridgemarketresearch.com/toc/?dbmr=global-neuroblastoma-drug-market

Key Development in the Market:

In May, 2018 Amneal Pharmaceuticals LLC     received the FDA approval for Cyclophosphamide drug which is generic to     Cytoxan and can be used as an injection. This is an important milestone     for the Amneal Pharmaceuticals LLC because they are focusing to enhance     their research and development on injectable products which can be     beneficial for patients and healthcare providers

In March 2015, United Therapeutics     Corporation received the FDA approval for dinutuximab drug for the     treatment of neuroblastoma, as part of first-line therapy for paediatric     patients with high-risk neuroblastoma

Competitive Analysis: Global Neuroblastoma Drug Market 

Global neuroblastoma drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global neuroblastoma drug market for global Europe North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players: Global Neuroblastoma Drug Market 

Few of the major competitors currently working in the global neuroblastoma drug market are Cellectar Biosciences, INC, United Therapeutics Corporation, APEIRON Biologics AG, Baxter, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Bayer AG, MacroGenics, Inc, Advaxis, Amgen Inc, AstraZeneca, Bristol-Myers Squibb Company, Curispharma, Eli Lilly and Company, GlaxoSmithKline plc, Marsala Biotech Inc, Merck KGaA, Merck & Co. Inc, Oncolytics Biotech, Inc, ONO PHARMACEUTICAL CO. LTD, Pfizer Inc, Pierre Fabre Group, Cyclacel Pharmaceuticals, Inc, BioDiem and others.

Research Methodology: Global Neuroblastoma Drug Market 

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

Current and future of global     neuroblastoma drug market outlook in the developed and emerging markets

The segment that is expected to dominate     the market as well as the segment which holds highest CAGR in the forecast     period

Regions/Countries that are expected to     witness the fastest growth rates during the forecast period

The latest developments, market shares,     and strategies that are employed by the major market players

Read other Report

Military     Communication Market

Nondestructive     Testing Services and Equipment Market

People     Counting System Market

Portable     Battery Pack Market

Protection     Relay Market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact: Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[leonfrancisblog]

Cardiac tamponade market is expected to gain market growth in the forecast period of 2020 to 2027| Key Players Medtronic, Boston Scientific Corporation, Abbott, Hitachi Ltd., Koninklijke Philips N.V., Siemens Healthcare Private Limited, Canon Medical Systems Corp.,

Cardiac Tamponade Market is estimated to grow at 5.5% for 2017-2024 with factors such as high price of surgery along with risk associated with the surgery will hinder the growth of the market in emerging economies. Cardiac tamponade market has shown an exceptional penetration in developed economies in North America. Increasing usage of extensive medications along with rising expenditure in healthcare industry will help in driving the growth of the market.

Rising prevalence of cardiac disorder due to changing lifestyle and growing awareness about those disorders are the key factors driving market growth. Moreover increasing screening and penetration of healthcare sector will fuel market growth whereas rising risks of diseases like kidney failure, end stage lung cancer, hypothyroidism will boost market growth in coming years. However high cost of surgeries related to cardiac tamponade and invasive nature of those surgeries are restraining factor for market whereas increasing demand for non invasive techniques and high cost of surgeries will be challenging factor for market to expand in developing economies. In addition with technological advancement and innovation of products with more efficiency and less invasiveness will create opportunities for market.

Global Cardiac Tamponade Market, By Diagnosis (X-Ray, Computed Tomography, Magnetic Resonance Imaging, Coronary Angiography, Electrocardiogram, Others), Treatment (Surgery, Drugs), End User (Hospitals, Clinics, Cardiac Centers, Academic Institutes, Research Institutes), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027This cardiac tamponade market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research cardiac tamponade market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Get Sample PDF of Cardiac tamponade market Report (including COVID19 Impact Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cardiac-tamponade-market

Cardiac Tamponade Market Development in 2020:

In February 2020, Merck & Co., Inc. announced the approval from FDA (Food and Drug Administration) regarding the biologics license application in various diseases. The approval will help in patients in recovering faster with the prevalence of advanced drugs and medications.

Scope of the Cardiac Tamponade Market:

Cardiac tamponade market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia-Pacific (APAC) as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

All country based analysis of the cardiac tamponade market is further analyzed based on maximum granularity into further segmentation. On the basis of diagnosis, the market is segmented into X-ray, computed tomography, magnetic resonance imaging, coronary angiography and electrocardiogram. Based on technology, the market is segmented into surgery and drugs. Based on end-user, the market has been segmented into hospitals, clinics, cardiac centers, academic institutes and research institutes.

Cardiac tamponade is a type of fluid around the heart that will results in the difficulty in the compression of the heart that will reduced blood pumped by the heart. Shortness of breath, cough, light headedness, fatigue is some of the symptoms of cardiac tamponade which causes kidney failure, chest trauma, aortic rupture and others.

Key Market Competitors:

The major players operating in the cardiac tamponade market report are Medtronic, Boston Scientific Corporation, Abbott, Hitachi Ltd., Koninklijke Philips N.V., Siemens Healthcare Private Limited, Canon Medical Systems Corp., GENERAL ELECTRIC COMPANY, Edwars Lifesciences, Summit Medical Group, Clinical Care Options LLC, Prezi, Inc., McLaren Healthcare, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Key Pointers Covered in the Cardiac Tamponade Market:

Market Size

Market New Sales Volumes

Market Replacement Sales Volumes

Market Installed Base

Market By Brands

Market Procedure Volumes

Market Product Price Analysis

Market Healthcare Outcomes

Market Cost of Care Analysis

Market Regulatory Framework and Changes

Market Prices and Reimbursement Analysis

Market Shares in Different Regions

Recent Developments for Market Competitors

Market Upcoming Applications

Market Innovators Study

MAJOR TOC OF THE REPORT:

Chapter One: Cardiac Tamponade Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Cardiac Tamponade Market Competition, by Players

Chapter Four: Cardiac Tamponade Market Size by Regions

Chapter Five: Cardiac Tamponade Market Revenue by Countries

Chapter Six: Cardiac Tamponade Market Revenue by Type

Chapter Seven: Cardiac Tamponade Market Revenue by Application

Chapter Eight: Cardiac Tamponade Market Revenue by Industries

Chapter Nine: Cardiac Tamponade Market Revenue by Deployment Model

Chapter Ten: Cardiac Tamponade Market Revenue by End User

Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=global-cardiac-tamponade-market

Reasons for Buying this Global Cardiac Tamponade Market Report

Laser Capture Global Cardiac Tamponade Market, report aids in understanding the crucial product segments and their perspective.

Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Global Cardiac Tamponade Market industry.

Even the Laser Capture Global Cardiac Tamponade Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.

This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.

This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.

The key questions answered in this report:

What will be the Market Size and Growth Rate in the forecast year?

What is the Key Factors driving Laser Capture Global Cardiac Tamponade Market?    

What are the Risks and Challenges in front of the market?

Who are the Key Vendors in Global Cardiac Tamponade Market?  

What are the Trending Factors influencing the market shares?

What is the Key Outcomes of Porter’s five forces model

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-cardiac-tamponade-market    

Browse Related Report:

Interventional Oncology Market

Medical Cyclotron Market

Cardiopulmonary Resuscitation (CRP) Devices Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[chitrakullkarni]

Urology Surgical Instruments Market Size Estimation, Growth Rate and Future Trends Analysis Report

The global Urology Surgical Instruments Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

Global Urology Surgical Instruments Market size is expected to reach USD 14.12 billion by 2025. Urology surgeries are associated with the treatment of urologic disease or dysfunction of female and male urinary tract. These surgeries also known as “genitourinary surgery”. Urologic disease or dysfunction in male include kidney stones, bladder control dysfunction, nephrectomy, prostate disorders, ureteral reimplants, pyeloplasty, and urinary retention. The market is expected to grow at a 7.9% CAGR in the forecast period.

Key Players:

Olympus Corporation

Coloplast Group

KARL STORZ GmbH

Richard Wolf GmbH

Cook

Boston Scientific Corporation

Medtronic

Teleflex Incorporated

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/urology-surgical-instruments-market/request-sample

Growth Drivers:

The factors that play an important role in the growth of market include increasing demand, growing geriatric population, increasing urbanization & industrialization, rising preference for minimally invasive surgeries, increasing prevalence of urinary disorders, surging R&D investments, growing healthcare industry, ongoing product launches by manufactures, and technological advancements. Moreover, rising number of hospitals, growing hospital investments in surgical infrastructure and availability of funds, investments & grants from government are expected to drive the market growth in the coming years.

However, increasing cost of urology endoscope & laparoscopic endovision system, high risk of complications associated with surgical procedures in geriatric patients and the other high pricing are negatively impacting the growth of urology surgical instruments industry. The Urology Surgical Instruments market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others.

Application Outlook:

Chronic Kidney Diseases (CKD)

Benign Prostatic Hyperplasia (BPH)

Urinary Stones

Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)

Oncology

The “chronic kidney diseases” segment is expected to hold the large market share in the upcoming period due to rising incidence of CKD, growing number of clinical trials for new non-invasive procedures to treat these diseases and increasing initiatives by governments globally. However, the “urinary incontinence & pelvic organ prolapse” segment is anticipated to grow at the higher CAGR in the coming years owing to significantly increasing number of surgical procedures for urinary incontinence, advancing technologies, growing awareness about incontinence and rising adoption of these products for managing incontinence.

Regional Outlook:

North America has been at the forefront with regards to urology surgical instruments market and will continue to rule the roost in the years to come. The increasing urology equipment purchases by hospitals, rising incidences of urology cancers & disorders, rise in number of urologists, increasing healthcare spending on urology disorders and positive reimbursement scenario are the factors likely to boost the Urology Surgical Instruments market growth in this region.

On the other hand, Asia Pacific is anticipated to grow at a high CAGR in the next couple of years owing to growing geriatric population, increasing healthcare expenditure for urology by governments, rapidly growing healthcare industry, improving healthcare infrastructure in India & China and stringent regulatory policies.

Browse Related Category Research Reports @ https://blog.naver.com/tomclark